Redhill Biopharma
RDHL
#11057
Rank
โ‚ฌ4.27 M
Marketcap
0,48ย โ‚ฌ
Share price
-6.75%
Change (1 day)
-67.17%
Change (1 year)

EPS for Redhill Biopharma (RDHL)

EPS in 2023 (TTM): -705,09ย โ‚ฌ

According to Redhill Biopharma's latest financial reports the company's current EPS (TTM) is -624,68ย โ‚ฌ. In 2017 the company made an earnings per share (EPS) of -2.231ย โ‚ฌ a decrease over its 2016 EPS that were of -1.963ย โ‚ฌ.

EPS history for Redhill Biopharma from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-705,09ย โ‚ฌ
2017-2.231ย โ‚ฌ13.64%
2016-1.963ย โ‚ฌ9.12%
2015-1.799ย โ‚ฌ68.01%
2014-1.071ย โ‚ฌ-25.93%
2013-1.446ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
1,70ย โ‚ฌ-100.27%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
1,13ย โ‚ฌ-100.18%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,85ย โ‚ฌ-100.46%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
0,56ย โ‚ฌ-100.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
1,09ย โ‚ฌ-100.17%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel